Healthcare Services

Cellular Therapy Tracking Market Growth Expected to Reach $5.3 Billion by 2030 with 12.8% CAGR

March 31, 2026March 31, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Value Is Anticipated For The Cellular Therapy Tracking Market Over The Period 2026–2030?

The cellular therapy tracking market size has experienced rapid growth in recent years. It is projected to expand from $2.9 billion in 2025 to $3.28 billion in 2026, at a compound annual growth rate (CAGR) of 13.1%. Historically, this growth can be attributed to increasing clinical trial activity for cell therapies, rising regulatory scrutiny on advanced therapies, the expansion of personalized medicine programs, the early adoption of digital tracking systems, and the broadening of biologics manufacturing.

The cellular therapy tracking market is poised for significant expansion over the coming years. Projections indicate its value will reach $5.31 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.8%. This anticipated growth during the forecast period is driven by factors such as the heightened commercialization of cell and gene therapies, a greater need for real-time therapy insights, the spread of decentralized clinical trials, a stronger emphasis on patient safety and adherence, and increased funding for digital health infrastructure. Key trends foreseen include the wider uptake of comprehensive therapy traceability platforms, greater incorporation of compliance and reporting software, more frequent application of real-time supply chain monitoring, the development of data-driven workflow optimization tools, and an increased commitment to regulatory clarity.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28162&type=smp

Which Economic Or Industry Drivers Are Impacting The Cellular Therapy Tracking Market?

The expanding integration of personalized medicine is anticipated to propel the cellular therapy tracking market’s growth in the foreseeable future. This medical strategy customizes treatment and prevention plans based on an individual’s distinct genetic profile, way of life, and surrounding conditions. Its rising uptake is largely attributed to progress in genomics, allowing for the precise identification of genetic differences and customized treatments for patients. Cellular therapy tracking aids personalized medicine by guaranteeing meticulous oversight and administration of patient-specific cells during the entire therapeutic process. This system improves the safety and effectiveness of treatments through complete traceability, adherence to regulations, and simplified operational procedures for healthcare professionals. For example, data from February 2024, provided by the US-based nonprofit, Personalized Medicine Coalition (PMC), indicates that the U.S. Food and Drug Administration (FDA) authorized 26 novel personalized medicines in 2023, marking a considerable rise from the 12 approvals in 2022. Consequently, the growing acceptance of personalized medicine is fueling expansion in the cellular therapy tracking market.

How Is The Cellular Therapy Tracking Market Divided Into Its Major Segments?

The cellular therapy tracking market covered in this report is segmented –

1) By Product Type: Software, Services

2) By Application: Cancer, Cardiovascular Diseases, Musculoskeletal Disorders, Autoimmune Diseases, Other Applications

3) By End-User: Hospitals, Research Institutes, Biotechnology Companies, Other End-Users

Subsegments:

1) By Software: Patient Registry Software, Clinical Trial Management Software, Electronic Data Capture (EDC) Systems, Laboratory Information Management Systems (LIMS), Cell Therapy Supply Chain Management Software, Compliance And Reporting Software, Data Analytics And Visualization Tools

2) By Services: Implementation And Integration Services, Training And Education Services, Consulting Services, Managed Services, Technical Support And Maintenance, Data Security And Compliance Services

What Key Trends Are Influencing The Development Of The Cellular Therapy Tracking Market?

Leading companies in the cellular therapy tracking sector are concentrating on developing adaptable platforms, including chain of identity (COI) management platforms, to guarantee the traceability of cells, adherence to regulatory requirements, and patient safety. Chain of identity (COI) management platforms are defined as digital systems that meticulously track and verify the identity of cells specific to each patient throughout the complete cellular therapy process, thereby ensuring both traceability and patient security. As an illustration, TrakCel Limited, a software company based in the UK, unveiled OCELLOS Core in May 2023. This new component of its OCELLOS suite is designed as a Chain of Identity (COI) management platform for autologous and personalized cell and gene therapy (CGT) clinical trials in their early stages. It delivers automated COI tracking, guaranteeing precise patient records from the very first enrollment. The system, which is pre-configured and validated, can be deployed within a mere 2–3 weeks, offering economical scalability as these therapies transition from trials to market. Additionally, it tracks all chain of custody events with complete audit trails, thereby improving compliance and inter-organizational collaboration.

Who Are The Prominent Organizations Shaping The Cellular Therapy Tracking Market?

Major companies operating in the cellular therapy tracking market are Johnson & Johnson, Novartis AG, Bristol-Myers Squibb Company, Thermo Fisher Scientific Inc., Gilead Sciences Inc., Merck KGaA, GE Healthcare Technologies Inc., Becton Dickinson and Company, Lonza Group Ltd., Nikon Corporation, Charles River Laboratories International Inc., Sartorius AG, Bio-Rad Laboratories Inc., Bio-Techne Corporation, Miltenyi Biotec B.V. & Co. KG, Promega Corporation, Vericel Corporation, Adaptimmune Therapeutics plc, Medipost Co. Ltd., TrakCel

Read the full cellular therapy tracking market report here:

https://www.thebusinessresearchcompany.com/report/cellular-therapy-tracking-global-market-report

What Are The Top-Performing Regions Within The Cellular Therapy Tracking Market?

North America was the largest region in the cellular therapy tracking market in 2025. The regions covered in the cellular therapy tracking market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Cellular Therapy Tracking Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28162&type=smp

Browse Through More Reports Similar to the Global Cellular Therapy Tracking Market 2026, By The Business Research Company

Drug Screening Global Market Report

https://www.thebusinessresearchcompany.com/report/drug-screening-global-market-report

Blood Screening Global Market Report

https://www.thebusinessresearchcompany.com/report/blood-screening-global-market-report

Cell Based Assays Global Market Report

https://www.thebusinessresearchcompany.com/report/cell-based-assays-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795